Our immunohistochemical studies revealed strong expression of FAM159B in tumours of endocrine or neuroendocrine origin, such as pituitary adenomas, BP-NEN and GEP-NEN, medullary and anaplastic thyroid carcinomas and parathyroid adenomas. This evidence concerns the gene SHISAL2B and pituitary gland adenoma.